MSCI vs CME
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MSCI · MSCI Inc$610.48 ▼ 2.22%
CME · CME Group$307.56 ▲ 0.41%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MSCI +11.3%
- CME +15.9%
Head to head
| Metric | MSCI | CME |
|---|---|---|
| Price | $610.48 | $307.56 |
| Change today | ▼ 2.22% | ▲ 0.41% |
| Market cap | $43.65B | $110.09B |
| Return, 3 months | +7.2% | +10.7% |
| Return, year to date | +7.9% | +16.5% |
| Return, 1 year | +10.2% | +17.0% |
| P/E (TTM) | 32.3 | 25.2 |
| P/B | -14.5 | 4.1 |
| P/E percentile vs own 5y | 7th | 68th |
| Dividend yield | 1.30% | 3.67% |
| Revenue growth (YoY, latest qtr) | +12.4% | +13.0% |
| Net profit growth (YoY) | +7.9% | +14.2% |
| Gross margin | 82.9% | 86.6% |
| Operating margin | 55.7% | 65.7% |
| Net margin | 40.3% | 63.1% |
| Return on equity | – | 16.1% |
| Analyst target vs. price | +13.0% | +2.0% |
| Analyst buy share | 90% | 55% |
| RSI (14) | 45 | 55 |
| 30-day volatility | 34.7% | 24.9% |
| Max drawdown, 1 year | -18.1% | -31.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CME is the largest of the group by market value.
- CME has returned the most over the past year.
- CME carries the lowest trailing P/E.
- CME pays the highest dividend yield.
- CME is growing revenue fastest.
- CME keeps the most profit per dollar of sales.
- CME has been the calmest stock over the last 30 days.